Advertisement

Weight loss and improved quality of life with a nonsurgical endoscopic treatment for obesity: clinical results from a 3- and 6-month study

      Abstract

      Background

      The TransPyloric Shuttle™ (TPS) is a nonsurgical device that is endoscopically delivered to and removed from the stomach to treat obesity. The device consists of a large spherical bulb connected to a smaller cylindrical bulb by a flexible tether. The larger bulb prevents migration from the stomach, while the smaller bulb passes freely into the duodenum to position the TPS across the pylorus. Transpyloric positioning may delay gastric emptying, reducing caloric intake and enabling weight loss. The purpose of this feasibility study was to evaluate the safety and efficacy of the clinical procedure and device.

      Methods

      Twenty patients with a mean body mass index (BMI) of 36.0 kg/m2 were assigned to 2 groups of 10 patients scheduled to have the device for 3 or 6 months. Primary outcomes included % excess weight loss (%EWL), % excess BMI loss (%EBMIL), % weight loss (%WL), and adverse events.

      Results

      Devices were deployed and retrieved in all patients with no complications. Three-month patients had mean %EWL of 25.1%, mean %EBMIL of 33.1%, and mean %WL of 8.9%. Six-month patients had mean %EWL of 41.0%, mean %EBMIL of 50.0%, and mean %WL of 14.5%. Early device removal occurred in 2 patients due to symptomatic gastric ulcerations, which resolved after device removal.

      Conclusions

      The TPS is a promising technology that provides a, nonsurgical, ambulatory method for weight loss.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Surgery for Obesity and Related Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Ogden C.L.
        • Carroll M.D.
        • Kit B.K.
        • Flegal K.M.
        Prevalence of obesity in the United States, 2009-2010.
        NCHS Data Brief. 2012; 82: 1-8
        • Finkelstein E.A.
        • Trogdon J.G.
        • Cohen J.W.
        • Dietz W.
        Annual medical spending attributable to obesity: Payer and service-specific estimates.
        Health Affairs. 2009; 28: w822-w831
        • Kolotkin R.L.
        • Crosby R.D.
        • Kosloski K.D.
        • Williams G.
        Development of a brief measure to assess quality of life in obesity.
        Obes Res. 2001; 9: 102-111
        • Sarwer D.B.
        • Wadden T.A.
        • Moore R.H.
        • Eisenber M.H.
        • Raper S.E.
        • Williams N.N.
        Changes in quality of life and body image following gastric bypass surgery.
        Surg Obes Relat Dis. 2010; 6: 608-614
        • Rexrode K.M.
        • Hennekens C.H.
        • Willett W.C.
        • et al.
        A prospective study of body mass index, weight change, and risk of stroke in women.
        JAMA. 1997; 277: 1539-1545
        • Glynn R.J.
        • Christen W.G.
        • Manson J.E.
        • Bernheimer J.
        • Hennekens C.H.
        body mass index an independent predictor of cataract.
        Arch Ophthalmol. 1995; 113: 1131-1137
        • Wang S.
        • Li P.
        • Sun X.F.
        • Ye N.Y.
        • Xu Z.K.
        • Wang D.
        Comparison between laparoscopic sleeve gastrectomy and laparoscopic adjustable gastric banding for morbid obesity: a meta-analysis.
        Obes Surg. 2013; 23: 980-986